PROMETHEUS Anser UST Build info

Synonyms

  • PROMETHEUS ANSER UST
  • PROMETHEUS Anser UST
  • ANSERUST
  • Ustekinumab
  • LAB10915

Short Name

PROMETHEUS ANSER UST

Procedure Master Number

LAB10915

Procedure ID

114326

Clinical Info

Simultaneously measures ustekinumab (UST) and antibodies to ustekinumab (UST) levels in serum at any time during therapy.
 
Quantify whether inflammatory bowel disease patients have antibodies and/or sufficient drug concentrations Measure antibodies in the presence of drugs (i.e., drug tolerant assay) Overcome many of the limitations of solid-phase assays Assay-specific drug and antibody levels correlated with clinical outcomes

Specimen Type

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube:   Gold top tube
Specimen: 2 mL serum (0.5 mL min)
Transport Temperature: 7 Days  Room Temperature 
                                          9 Days  Refrigerated

Transport Instructions

7 Days  Room Temperature

Specimen Stability

Methodology

Electrochemiluminescence Immunoassay (ECLIA)
 
Test Includes:  Ustekinumab (UST) and antibodies-to-ustekinumab (ATU) levels

Days Performed

Monday - Friday
  TAT = 4 days

Performing Laboratory

Prometheus Therapeutics & Diagnostics

CPT

80299
82542- Ab

PDM

2059731

Results
Component Name Base Name Common Name External Name
PROMETHEUS ANSER UST PROMANUST PROMETHEUS ANSER UST Prometheus Anser Ust
PROMETHEUS LABORATORY FOOTER PROMLABFT PROMETHEUS LABORATORY FOOTER Prometheus Laboratory Footer
SERUM USTEKINUMAB CONCENTRATION SERUMUSTE SERUM USTEKINUMAB CONCENTRATION Serum Ustekinumab Concentration
USTEKINUMAB ANTIBODIES CONCENTRATION USTEANT USTEKINUMAB ANTIBODIES CONCENTRATION Ustekinumab Antibodies Concentration